Michael J. Gerber
22Patents
7h-index
23Co-inventors
69Inventor score
Filing activity: Mar 8, 1994 → Nov 23, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5631219A | Method of stimulating hematopoiesis with hemoglobin | Emerging Cross-Sectional Technologies | 46 | Expired |
| US5677330A | Medical uses of allosteric hemoglobin modifier compounds in patient care | Chemistry; Metallurgy | 33 | Expired |
| US6214879A | Allosteric inhibitors of pyruvate kinase | Human Necessities | 31 | Expired |
| US5927283A | Allosteric modifiers of hemoglobin | Chemistry; Metallurgy | 17 | Expired |
| US8865730B2 | Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one | Chemistry; Metallurgy | 17 | Active |
| US8377933B2 | Method for treating a pulmonary hypertension condition | Human Necessities | 8 | Active |
| US9469643B2 | Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one | Chemistry; Metallurgy | 7 | Active |
| US8865650B2 | Therapy for complications of diabetes | Human Necessities | 7 | Active |
| US8600479B2 | Guidance and implantation of catheters | Emerging Cross-Sectional Technologies | 6 | Active |
| US6242417A | Stabilized compositions containing hemoglobin | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5750132A | Treatment of adverse effects associated with administration of extracellular hemoglobin | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5914391A | Stabilized compositions containing hemoglobin | Emerging Cross-Sectional Technologies | 4 | Expired |
| US9592231B2 | Therapy for complications of diabetes | Human Necessities | 4 | Active |
| US5827888A | Perinatal treatment of a fetus to avoid oxygen deprivation | Human Necessities | 4 | Expired |
| US8623819B2 | Therapy for complications of diabetes | Human Necessities | 4 | Active |
| US8470295B2 | Methods of treatment of androgenic steroidal hormone dependent cancer with auger electron-emitting nucleoside analogs | Human Necessities | 2 | Active |
| US10730879B2 | Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one | Chemistry; Metallurgy | 2 | Active |
| US7097825B2 | Methods and reagents to acquire MRI signals and images | Emerging Cross-Sectional Technologies | 2 | Expired |
| US9504685B2 | Method for treating a pulmonary hypertension condition | Human Necessities | 1 | Active |
| US9993475B2 | Method for treating a pulmonary hypertension condition | Human Necessities | 0 | Active |
| US9283223B2 | Method for treating a pulmonary hypertension condition | General | 0 | Revoked |
| US9474752B2 | Method for treating a pulmonary hypertension condition | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.